Saskatchewan Blue Cross' $50,000 gift points to a not-for-profit model with a direct stake in public system capacity
Alberta plan sponsors face a projected increase in drug claims as Bill 11 shifts costs to private plans starting October 1
Cost control tops global benefits priorities in 2026, but most Canadian employers are refusing to cut coverage or shift costs to workers
Medavie Blue Cross’ Marie-Hélène Dugal explains how generic semaglutide is reigniting mandatory generic substitution in plans
Nigel Branker explains why 'better outcomes start with better access' for women
Consultants share how fiduciary duty plays a critical role in managing plan sponsors’ challenges and benefits plans
